Nanexa AB (OSTO:NANEXA) Total Liabilities : kr27.45 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB Total Liabilities?

Nanexa AB's Total Liabilities for the quarter that ended in Jun. 2024 was kr27.45 Mil.

Nanexa AB's quarterly Total Liabilities declined from Dec. 2023 (kr36.43 Mil) to Mar. 2024 (kr30.90 Mil) and declined from Mar. 2024 (kr30.90 Mil) to Jun. 2024 (kr27.45 Mil).

Nanexa AB's annual Total Liabilities increased from Dec. 2021 (kr13.70 Mil) to Dec. 2022 (kr61.10 Mil) but then declined from Dec. 2022 (kr61.10 Mil) to Dec. 2023 (kr36.43 Mil).

Nanexa AB Total Liabilities Historical Data

The historical data trend for Nanexa AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanexa AB Total Liabilities Chart

Nanexa AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

10.56

10.34

13.70

61.10

36.43

Nanexa AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Liabilities	Get a 7-Day Free Trial															50.35	40.98	36.43	30.90	27.45

Nanexa AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nanexa AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	30.574	+	(2.087	+	3.766
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	36.43

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	132.257	-	95.83
	=	36.43

Nanexa AB's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	25.474	+	(1.539	+	0.44
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	27.45

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	114.447	-	86.994
	=	27.45

Nanexa AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nanexa AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanexa AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Virdings Alle 32B, Uppsala, SWE, 75450

Website

https://www.nanexa.com

Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

Nanexa AB Headlines

No Headlines